TSE:EXE Extendicare (EXE) Stock Price, News & Analysis → The most important AI company you've never heard of (From Manward Press) (Ad) Free EXE Stock Alerts C$7.23 -0.49 (-6.35%) (As of 01:57 PM ET) Add Compare Share Share Today's RangeC$7.20▼C$7.7250-Day RangeC$6.71▼C$7.8852-Week RangeC$5.75▼C$7.90Volume421,529 shsAverage Volume120,641 shsMarket CapitalizationC$602.84 millionP/E Ratio18.08Dividend Yield6.64%Price TargetC$8.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlines Get Extendicare alerts: Email Address Extendicare MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside9.9% UpsideC$8.00 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.00Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.24 out of 5 stars 1.3 Analyst's Opinion Consensus RatingExtendicare has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageExtendicare has only been the subject of 3 research reports in the past 90 days.Read more about Extendicare's stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for EXE. Previous Next 1.7 Dividend Strength Dividend LeadershipExtendicare is a leading dividend payer. It pays a dividend yield of 6.25%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthExtendicare does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Extendicare is 120.00%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about Extendicare's dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EXE. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 2 news articles for Extendicare this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for EXE on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Extendicare insiders have not sold or bought any company stock.Percentage Held by Insiders13.92% of the stock of Extendicare is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 20.23% of the stock of Extendicare is held by institutions.Read more about Extendicare's insider trading history. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Extendicare is 18.20, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 145.49.Price to Earnings Ratio vs. SectorThe P/E ratio of Extendicare is 18.20, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 185.99.Price to Book Value per Share RatioExtendicare has a P/B Ratio of 6.87. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Monetary GoldTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. About Extendicare Stock (TSE:EXE)Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.Read More EXE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EXE Stock News HeadlinesMay 16 at 4:52 AM | americanbankingnews.comExtendicare (TSE:EXE) Shares Cross Above Two Hundred Day Moving Average of $7.09May 8, 2024 | americanbankingnews.comExtendicare (EXE) to Release Earnings on WednesdayMay 6, 2024 | finance.yahoo.comThose who invested in Extendicare (TSE:EXE) a year ago are up 18%April 30, 2024 | finance.yahoo.comAlayaCare Selected by ParaMed as Technology Platform to Power Home Health Care Across CanadaApril 9, 2024 | theglobeandmail.comContra Guys: As seniors’ population rises, Extendicare worth a lookApril 8, 2024 | finance.yahoo.comCan Extendicare Inc. (TSE:EXE) Maintain Its Strong Returns?April 4, 2024 | theglobeandmail.comExtendicare Announces Timing of 2024 First Quarter Results and Conference CallApril 4, 2024 | finance.yahoo.comExtendicare Announces Timing of 2024 First Quarter Results and Conference CallMarch 20, 2024 | fool.caInvest $374.50 Each Month to Create Passive Income of $288 in 2024March 10, 2024 | seekingalpha.comExtendicare Inc. (EXETF) Q4 2023 Earnings Call TranscriptMarch 8, 2024 | finanznachrichten.deExtendicare Inc: Extendicare Announces 2023 Fourth Quarter and Year End ResultsMarch 8, 2024 | msn.comExtendicare GAAP EPS of C$0.10, revenue of C$350.18MFebruary 20, 2024 | finance.yahoo.comIs Now An Opportune Moment To Examine Extendicare Inc. (TSE:EXE)?February 15, 2024 | finance.yahoo.comExtendicare Opens the MarketJanuary 19, 2024 | finance.yahoo.comExtendicare Announces Timing of 2023 Fourth Quarter Results and Conference CallJanuary 15, 2024 | finance.yahoo.comExtendicare Announces January 2024 Dividend of C$0.04 per ShareDecember 23, 2023 | seekingalpha.comEXE:CA Extendicare Inc.December 15, 2023 | finance.yahoo.comExtendicare Announces December 2023 Dividend of C$0.04 per ShareNovember 9, 2023 | finance.yahoo.comExtendicare Announces 2023 Third Quarter ResultsOctober 19, 2023 | theglobeandmail.comClosing Bell: Extendicare Inc flat on Thursday (EXE)October 16, 2023 | finance.yahoo.comExtendicare Announces October 2023 Dividend of C$0.04 per ShareOctober 11, 2023 | finance.yahoo.comExtendicare Inc.'s (TSE:EXE) Intrinsic Value Is Potentially 61% Above Its Share PriceSeptember 15, 2023 | finance.yahoo.comExtendicare Announces September 2023 Dividend of C$0.04 per ShareSeptember 14, 2023 | finanznachrichten.deExtendicare Inc: Extendicare Announces Closing of Transaction with AxiumSeptember 14, 2023 | finance.yahoo.comEXE.TO - Extendicare Inc.See More Headlines Receive EXE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/07/2024Ex-Dividend for 4/15 Dividend3/27/2024Dividend Payable4/15/2024Ex-Dividend for 5/15 Dividend4/29/2024Dividend Payable5/15/2024Today5/16/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Medical Care Facilities Sub-IndustryN/A Current SymbolTSE:EXE CUSIPN/A CIKN/A Webwww.extendicare.com Phone905-470-4000FaxN/AEmployees23,000Year FoundedN/APrice Target and Rating Average Stock Price TargetC$8.00 High Stock Price TargetC$8.50 Low Stock Price TargetC$7.50 Potential Upside/Downside+3.6%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)C$0.40 Trailing P/E Ratio19.30 Forward P/E Ratio19.78 P/E GrowthN/ANet IncomeC$33.98 million Net Margins2.60% Pretax MarginN/A Return on Equity36.03% Return on Assets6.84% Debt Debt-to-Equity Ratio380.48 Current Ratio0.83 Quick Ratio0.98 Sales & Book Value Annual SalesC$1.30 billion Price / Sales0.50 Cash FlowC$2.41 per share Price / Cash Flow3.20 Book ValueC$1.06 per share Price / Book7.28Miscellaneous Outstanding Shares83,380,000Free FloatN/AMarket CapC$643.69 million OptionableNot Optionable Beta1.23 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesDr. Michael R. Guerriere M.D. (Age 59)MBA, CEO, President & Director Comp: $1.21MMr. David E. BaconSenior VP & CFOJoe BelinskyVP of Information Technology & Chief Information OfficerMs. Jillian E. FountainVice President of Investor RelationsMs. Kathryn Killoran BradleyVice President of Corporate DevelopmentMs. Katie LeMoyneSenior VP & Chief Human Resources OfficerMs. Wendy GilmourSenior Vice President of Long-term Care OperationsMs. Amie Cathleen VahrmeyerVice President of Long-Term Care Operations for ONMore ExecutivesKey CompetitorsWELL Health TechnologiesTSE:WELLMedical FacilitiesTSE:DRSienna Senior LivingTSE:SIAdentalcorpTSE:DNTLKnight TherapeuticsTSE:GUDView All Competitors EXE Stock Analysis - Frequently Asked Questions Should I buy or sell Extendicare stock right now? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Extendicare in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" EXE shares. View EXE analyst ratings or view top-rated stocks. What is Extendicare's stock price target for 2024? 4 brokerages have issued 1-year target prices for Extendicare's shares. Their EXE share price targets range from C$7.50 to C$8.50. On average, they expect the company's share price to reach C$8.00 in the next year. This suggests a possible upside of 9.9% from the stock's current price. View analysts price targets for EXE or view top-rated stocks among Wall Street analysts. How have EXE shares performed in 2024? Extendicare's stock was trading at C$7.28 at the start of the year. Since then, EXE stock has increased by 0.0% and is now trading at C$7.28. View the best growth stocks for 2024 here. How were Extendicare's earnings last quarter? Extendicare Inc. (TSE:EXE) issued its earnings results on Thursday, March, 7th. The company reported $0.10 earnings per share (EPS) for the quarter. The business had revenue of $350.18 million for the quarter. Extendicare had a trailing twelve-month return on equity of 36.03% and a net margin of 2.60%. How often does Extendicare pay dividends? What is the dividend yield for Extendicare? Extendicare declared a monthly dividend on Monday, April 15th. Investors of record on Tuesday, April 30th will be given a dividend of 0.04 per share on Wednesday, May 15th. This represents a $0.48 annualized dividend and a yield of 6.59%. The ex-dividend date of this dividend is Monday, April 29th. Read our dividend analysis for EXE. Is Extendicare a good dividend stock? Extendicare (TSE:EXE) pays an annual dividend of C$0.48 per share and currently has a dividend yield of 6.25%. EXE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 120.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for EXE. What other stocks do shareholders of Extendicare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Extendicare investors own include Inter Pipeline (IPL), Pembina Pipeline (PPL), BCE (BCE), Chorus Aviation (CHR), Cenovus Energy (CVE), Medical Facilities (DR), Martinrea International (MRE), Air Canada (AC), AltaGas (ALA) and Emera (EMA). How do I buy shares of Extendicare? Shares of EXE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:EXE) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Extendicare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.